Mangoceuticals (MGRX) Cash from Operations (2023 - 2025)
Historic Cash from Operations for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to -$1.2 million.
- Mangoceuticals' Cash from Operations fell 647.0% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.9 million, marking a year-over-year decrease of 865.49%. This contributed to the annual value of -$4.9 million for FY2024, which is 3049.14% up from last year.
- According to the latest figures from Q3 2025, Mangoceuticals' Cash from Operations is -$1.2 million, which was down 647.0% from -$1.3 million recorded in Q2 2025.
- In the past 5 years, Mangoceuticals' Cash from Operations registered a high of -$991131.0 during Q1 2024, and its lowest value of -$2.3 million during Q1 2025.
- In the last 3 years, Mangoceuticals' Cash from Operations had a median value of -$1.6 million in 2024 and averaged -$1.5 million.
- In the last 5 years, Mangoceuticals' Cash from Operations skyrocketed by 4519.0% in 2024 and then crashed by 12951.37% in 2025.
- Mangoceuticals' Cash from Operations (Quarter) stood at -$1.7 million in 2023, then soared by 33.47% to -$1.1 million in 2024, then dropped by 9.89% to -$1.2 million in 2025.
- Its Cash from Operations stands at -$1.2 million for Q3 2025, versus -$1.3 million for Q2 2025 and -$2.3 million for Q1 2025.